KRAS and MT-CO1 genes in colorectal cancer: a molecular investigation

Harmand A Hama1, Bestoon S Hasan2, Basak Barzngy3

  • 1Department of Biology, Faculty of Education, Tishk International University, Erbil, Kurdistan Region of Iraq. harmand.ali@tiu.edu.iq.

Insights

This study found elevated KRAS oncogene expression in colorectal cancer (CRC) tissues, while MT-CO1 tumor suppressor gene expression showed no significant difference. A negative correlation was observed between MT-CO1 and KRAS in CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
  • The tumor suppressor gene MT-CO1 and the oncogene KRAS play critical roles in cell regulation.
  • Dysregulation of MT-CO1 and KRAS is implicated in cancer development.

Purpose of the Study:

  • To investigate the expression levels of KRAS and MT-CO1 in colorectal cancer (CRC) biopsy specimens.
  • To explore the relationship between KRAS and MT-CO1 expression in CRC patients.
  • To assess the potential of these genes as biomarkers for CRC detection and prognosis.

Main Methods:

  • Analysis of 42 colorectal cancer tissue samples and corresponding controls.
  • Assessment of KRAS and MT-CO1 gene expression using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR).
  • Statistical analysis including Chi-square and correlation tests (p<0.05).

Main Results:

  • KRAS expression was significantly upregulated in CRC tissues compared to controls (p=0.0001).
  • MT-CO1 expression did not show a significant difference between CRC tissues and controls (p=0.12).
  • A significant negative correlation was found between MT-CO1 and KRAS expression in CRC tissues (p=0.0001, r=-0.047).

Conclusions:

  • Variations in KRAS and MT-CO1 expression and their correlation may serve as indicators for CRC detection and prognosis.
  • Further research is needed to elucidate the underlying mechanisms of these gene interactions in CRC.
  • These findings could contribute to advancements in translational research for colorectal cancer.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K